JSK Therapeutics, Inc.

JSK Therapeutics, JSKT, is an early stage pharmaceutical company created to develop a new class of cancer treatment drugs which exploit nitric oxide release to selectively kill cancer cells. The company has exclusive licenses for the proprietary agents, their use in cancer treatment and formulation technology.